September 15, 2018
5:00 p.m.
Registration
Venue: Galaxy Hotel, Gęsia Street
Venue: Galaxy Hotel, Gęsia Street
6:00 p.m. - 6:30 p.m.
Welcome message
Venue: Galaxy Hotel, Gęsia Street
Chairs - Honorary Committee & Organizing Committee
Venue: Galaxy Hotel, Gęsia Street
Chairs - Honorary Committee & Organizing Committee
6:30 p.m. - 7:15 p.m.
Inaugural lecture
Venue: Galaxy Hotel, Gęsia Street
Margaret Haney Columbia University Medical Center, NY, USA
Cannabis intoxication, withdrawal and relapse: Human laboratory studies
Chairs - Władysław Lasoń (Poland )
Venue: Galaxy Hotel, Gęsia Street
Margaret Haney Columbia University Medical Center, NY, USA
Cannabis intoxication, withdrawal and relapse: Human laboratory studies
Chairs - Władysław Lasoń (Poland )
7:30 p.m. - 8:15 p.m.
Music Performance
Venue: Galaxy Hotel, Gęsia Street
Venue: Galaxy Hotel, Gęsia Street
8:15 p.m. - 11:00 p.m.
Welcome party
Venue: Galaxy Hotel, Gęsia Street
Venue: Galaxy Hotel, Gęsia Street
September 16, 2018
8:00 a.m. - 5:00 p.m.
REGISTRATION
Venue: Auditorium Maximum, 33 Krupnicza Street
Venue: Auditorium Maximum, 33 Krupnicza Street
8:45 a.m. - 10:45 a.m.
Session 1: Toxic factors in the brain: a constant challenge to neurobiology
Chair - Małgorzata Kajta (Poland ), Cordian Beyer (Germany )
Chair - Małgorzata Kajta (Poland ), Cordian Beyer (Germany )
Room: Medium Hall A
Speakers:
Cordian Beyer (Uniklinik - RWTH Aachen, Aachen – Germany )
Estrogen and brain inflammation.
Elżbieta Salińska (Mossakowski Medical Research Centre, Polish Academy of Sciences, Warsaw, Poland )
Hyperbaric and hypobaric treatment prevent radical oxygen species (ROS) toxicity in birth asphyxia.
Magdalena Zielińska (Mossakowski Medical Research Centre, Polish Academy of Sciences, Warsaw, Poland )
Astrocytic SN1 glutamine transporter in hyperammonemic encephalopathies.
Małgorzata Kajta (Institute of Pharmacology Polish Academy of Sciences, Krakow, Poland )
Steroid and xenobiotic receptor signaling in pathologies of the nervous system.
Cordian Beyer (Uniklinik - RWTH Aachen, Aachen – Germany )
Estrogen and brain inflammation.
Elżbieta Salińska (Mossakowski Medical Research Centre, Polish Academy of Sciences, Warsaw, Poland )
Hyperbaric and hypobaric treatment prevent radical oxygen species (ROS) toxicity in birth asphyxia.
Magdalena Zielińska (Mossakowski Medical Research Centre, Polish Academy of Sciences, Warsaw, Poland )
Astrocytic SN1 glutamine transporter in hyperammonemic encephalopathies.
Małgorzata Kajta (Institute of Pharmacology Polish Academy of Sciences, Krakow, Poland )
Steroid and xenobiotic receptor signaling in pathologies of the nervous system.
8:45 a.m. - 10:45 a.m.
Session 2: Rare diseases - every-day reality of neurology
Session within the continuous training of professional Pharmacists
Chairs - Joanna Pera (Poland ), Jolanta Sykut-Cegielska (Poland )
Session within the continuous training of professional Pharmacists
Chairs - Joanna Pera (Poland ), Jolanta Sykut-Cegielska (Poland )
Room: Medium Hall B
Speakers:
Zbigniew A. Gaciong (Medical University of Warsaw, Warsaw, Poland )
What can we offer patients with rare vascular diseases?
Jolanta Sykut-Cegielska (Department of Inborn Errors of Metabolism and Paediatrics, Institute of Mother and Child, Warsaw, Poland )
Inborn errors of metabolism as rare diseases.
Tomasz Dziedzic (Jagiellonian University Medical College, Krakow, Poland )
Autoimmune encephalopathies: rare, but treatable neurological disorders.
Joanna Pera (Jagiellonian University Medical College, Krakow, Poland )
Adrenoleukodystrophy - beyond fatty acids.
Zbigniew A. Gaciong (Medical University of Warsaw, Warsaw, Poland )
What can we offer patients with rare vascular diseases?
Jolanta Sykut-Cegielska (Department of Inborn Errors of Metabolism and Paediatrics, Institute of Mother and Child, Warsaw, Poland )
Inborn errors of metabolism as rare diseases.
Tomasz Dziedzic (Jagiellonian University Medical College, Krakow, Poland )
Autoimmune encephalopathies: rare, but treatable neurological disorders.
Joanna Pera (Jagiellonian University Medical College, Krakow, Poland )
Adrenoleukodystrophy - beyond fatty acids.
10:45 a.m. - 11:15 a.m.
Coffee break
11:15 a.m. - 11:30 a.m.
Sponsor presentation
Karolina Osowska (Selvita S.A.) Selvita R&D portfolio overview.
Karolina Osowska (Selvita S.A.) Selvita R&D portfolio overview.
Medium Hall
11:30 a.m. - 12:15 p.m.
Plenary Lecture 1:
Francesco Pavone - University of Florence, Italy
Morpho-functional imaging: connecting a single neuron to whole brain.
Francesco Pavone - University of Florence, Italy
Morpho-functional imaging: connecting a single neuron to whole brain.
Room: Medium Hall
Chair: Irena Nalepa (Poland
12:15 p.m. - 2:00 p.m.
Lunch Break
Room: Exhibition Room
12:15 p.m. - 2:00 p.m.
Poster Session 1
Room: Exhibition Room
2:00 p.m. - 4:00 p.m.
Session 3: New basic research on „legal highs”
Session within the continuous training of professional Pharmacists
Chairs - Krystyna Gołembiowska (Poland ), Liana Fattore (Italy )
Session within the continuous training of professional Pharmacists
Chairs - Krystyna Gołembiowska (Poland ), Liana Fattore (Italy )
Room: Medium Hall A
Speakers:
Dariusz Zuba (Institute of Forensic Research, Krakow, Poland )
Recent developments in the new psychoactive substances market.
Linda Simmler (University of Geneva, Switzerland )
Pharmacology of cathinones and related psychostimulants.
Liana Fattore (CNR Neuroscience Institute-Cagliari, National Research Council, Italy )
Studies on the ketamine-like compound metoxetamine (MXE), a dissociative new drug.
Krystyna Gołembiowska (Institute of Pharmacology PAS, Krakow, Poland )
Neurochemical effects of hallucinogens: similarities and differences.
Dariusz Zuba (Institute of Forensic Research, Krakow, Poland )
Recent developments in the new psychoactive substances market.
Linda Simmler (University of Geneva, Switzerland )
Pharmacology of cathinones and related psychostimulants.
Liana Fattore (CNR Neuroscience Institute-Cagliari, National Research Council, Italy )
Studies on the ketamine-like compound metoxetamine (MXE), a dissociative new drug.
Krystyna Gołembiowska (Institute of Pharmacology PAS, Krakow, Poland )
Neurochemical effects of hallucinogens: similarities and differences.
2:00 p.m. - 4:00 p.m.
Session 4: Translating scientific advances into therapies for neurodegenerative diseases
Chair - Doctor Katarzyna Kuter (Poland )
Chair - Doctor Katarzyna Kuter (Poland )
Room: Medium Hall B
Speakers:
M. Angela Cenci (Basal Ganglia Pathophysiology Unit, Lund University, Sweden )
Bridging the translational gap in Parkinson’s disease: challenges and opportunities.
Katarzyna Kuter (Institute of Pharmacology PAS, Krakow, Poland )
Astrocytes and brain compensation potential in Parkinson’s disease.
Bianca Marchetti (University of Catania Medical School, Catania, Italy & and OASI Institute for Research and Care on Mental Retardation and Brain Aging, Troina, Italy )
Translating neurorestorative approaches targeting astrocytes as drivers of neurorepair for next generation therapies in Parkinson’s disease.
M. Angela Cenci (Basal Ganglia Pathophysiology Unit, Lund University, Sweden )
Bridging the translational gap in Parkinson’s disease: challenges and opportunities.
Katarzyna Kuter (Institute of Pharmacology PAS, Krakow, Poland )
Astrocytes and brain compensation potential in Parkinson’s disease.
Bianca Marchetti (University of Catania Medical School, Catania, Italy & and OASI Institute for Research and Care on Mental Retardation and Brain Aging, Troina, Italy )
Translating neurorestorative approaches targeting astrocytes as drivers of neurorepair for next generation therapies in Parkinson’s disease.
4:00 p.m. - 4:30 p.m.
Coffee break
4:30 p.m. - 6:30 p.m.
Session 5: A way to consolidate your research independence – presentations from successful ERC grant applicants
Chairs - Jan Rodriguez Parkitna (Poland ), Umberto Spampinato (Italy )
Chairs - Jan Rodriguez Parkitna (Poland ), Umberto Spampinato (Italy )
Room: Medium Hall
Speakers:
János Szabadics (Institute of Experimental Medicine, HAS, Budapest, Hungary )
Direct measurement of electrical signaling from the smallest axon terminals
Ragnhildur Thóra Káradóttir (MRC Stem Cell Institute, University of Cambridge, UK )
Neuronal regulation of (re)myelination.
Simon Hippenmeyer (Institute of Science and Technology Austria, Klosterneuburg, Austria )
Principles of neural steam cell lineage progression in cerebral cortex development.
János Szabadics (Institute of Experimental Medicine, HAS, Budapest, Hungary )
Direct measurement of electrical signaling from the smallest axon terminals
Ragnhildur Thóra Káradóttir (MRC Stem Cell Institute, University of Cambridge, UK )
Neuronal regulation of (re)myelination.
Simon Hippenmeyer (Institute of Science and Technology Austria, Klosterneuburg, Austria )
Principles of neural steam cell lineage progression in cerebral cortex development.
September 17, 2018
8:00 a.m. - 5:00 p.m.
REGISTRATION
Venue: Auditorium Maximum, 33 Krupnicza Street
Venue: Auditorium Maximum, 33 Krupnicza Street
8:45 a.m. - 10:45 a.m.
Session 6: Obesity and diabetes: what needs to be identified and how to optimise treatment?
Session within the continuous training of professional Pharmacists
Chair - Agnieszka Dobrzyń (Poland ), Harini Sampath (USA )
Session within the continuous training of professional Pharmacists
Chair - Agnieszka Dobrzyń (Poland ), Harini Sampath (USA )
Room: Medium Hall A
Speakers:
Harini Sampath (Rutgers Center for Lipid Research, Rutgers University, NJ, USA )
Oxidative DNA damage: a novel player in the etiology of obesity.
Grzegorz Sumara (Rudolf Virchow Center for Experimental Biomedicine University of Würzburg, Würzburg, Germany )
Signaling cascades in metabolic diseases.
Agnieszka Dobrzyń (Nencki Institute of Experimental Biology, PAS, Warsaw, Poland )
Lipid Mediators in Regulation of Pancreatic Islet Function.
Jan Kopecky (Institute of Physiology CAS, Prague, Czech Republic )
Healthy adipocyte.
Harini Sampath (Rutgers Center for Lipid Research, Rutgers University, NJ, USA )
Oxidative DNA damage: a novel player in the etiology of obesity.
Grzegorz Sumara (Rudolf Virchow Center for Experimental Biomedicine University of Würzburg, Würzburg, Germany )
Signaling cascades in metabolic diseases.
Agnieszka Dobrzyń (Nencki Institute of Experimental Biology, PAS, Warsaw, Poland )
Lipid Mediators in Regulation of Pancreatic Islet Function.
Jan Kopecky (Institute of Physiology CAS, Prague, Czech Republic )
Healthy adipocyte.
8:45 a.m. - 10:45 a.m.
Session 7: Pharmacogenetics and personalized medicine
Session within the continuous training of professional Pharmacists
Chairs - W. Anna Daniel (Poland ), Julia Stingl (Germany )
Session within the continuous training of professional Pharmacists
Chairs - W. Anna Daniel (Poland ), Julia Stingl (Germany )
Room: Medium Hall B
Speakers:
Władysława Anna Daniel (Institute of Pharmacology, PAS, Krakow, Poland )
Introduction to pharmacogenetics.
Julia Stingl (Centre for Translational Medicine, University Bonn, Germany )
Mindful pharmacogenetics: the role of cytochrome P450 enzymes in drug metabolism and mental health.
Mateusz Kurzawski (Pomeranian Medical University, Szczecin, Poland )
Genetic factors and personalized medicine in Parkinson's disease.
Ewa Grzybowska (Centre of Oncology, MSC Memorial Institute, Gliwice, Poland )
“Genetic variation of response to treatment and toxic effects of FACregimen chemotherapy of breast cancer”
Ewa Wypasek (John Paul II Hospital, Kraków, Andrzej Frycz Modrzewski Cracow University, Jagiellonian University School of Medicine, Kraków, Poland )
Genetic predictors of bleeding in patients treated with vitamin K antagonists: new insight.
Władysława Anna Daniel (Institute of Pharmacology, PAS, Krakow, Poland )
Introduction to pharmacogenetics.
Julia Stingl (Centre for Translational Medicine, University Bonn, Germany )
Mindful pharmacogenetics: the role of cytochrome P450 enzymes in drug metabolism and mental health.
Mateusz Kurzawski (Pomeranian Medical University, Szczecin, Poland )
Genetic factors and personalized medicine in Parkinson's disease.
Ewa Grzybowska (Centre of Oncology, MSC Memorial Institute, Gliwice, Poland )
“Genetic variation of response to treatment and toxic effects of FACregimen chemotherapy of breast cancer”
Ewa Wypasek (John Paul II Hospital, Kraków, Andrzej Frycz Modrzewski Cracow University, Jagiellonian University School of Medicine, Kraków, Poland )
Genetic predictors of bleeding in patients treated with vitamin K antagonists: new insight.
10:45 a.m. - 11:15 a.m.
Coffee Break
11:15 a.m. - 11:30 a.m.
Sponsor presentation
Monika Lamparska-Przybysz (Polpharma Group)
Innovative Biologics and Biosimilars R&D and Manufacturing.
Monika Lamparska-Przybysz (Polpharma Group)
Innovative Biologics and Biosimilars R&D and Manufacturing.
Medium Hall
11:30 a.m. - 12:15 p.m.
Plenary Lecture 3:
Ulrik Gether - University of Copenhagen, Denmark
The dopamine transporter: a key player in psychostimulant addiction and dopaminergic pathologies
Ulrik Gether - University of Copenhagen, Denmark
The dopamine transporter: a key player in psychostimulant addiction and dopaminergic pathologies
Room: Medium Hall
Chair: Edmund Przegaliński (Poland
12:15 p.m. - 2:00 p.m.
Lunch Break
Room: Exhibition Room
12:15 p.m.- 2:00 p.m.
Poster Session 2
Room: Exhibition Room
2:00 p.m. - 4:00 p.m.
Session 8: From nanotechnology to nanomedicine
Chair - Ireneusz Grudziński (Poland )
Chair - Ireneusz Grudziński (Poland )
Room: Medium Hall A
Speakers:
Witold Łojkowski (Institute of High Pressure Physics of the Polish Academy of Sciences, Warsaw, Poland )
Hydroxyapatite nanoparticles: Past, present, and future in bone regeneration.
Tomasz Ciach (Warsaw University of Technology, Warsaw, Poland )
Cancer nanotechnology: Beyond the horizon.
Leszek Stobiński (Warsaw University of Technology, Warsaw, Poland )
Carbon nanoparticles for future nanomedicine.
Marcin Kruszewski (Institute of Nuclear Chemistry and Technology, Warsaw, Poland )
New look into theranostic nanoparticles in nuclear medicine.
Anna Nowicka (University of Warsaw, Warsaw, Poland )
Nanosensors in POC diagnostics.
Witold Łojkowski (Institute of High Pressure Physics of the Polish Academy of Sciences, Warsaw, Poland )
Hydroxyapatite nanoparticles: Past, present, and future in bone regeneration.
Tomasz Ciach (Warsaw University of Technology, Warsaw, Poland )
Cancer nanotechnology: Beyond the horizon.
Leszek Stobiński (Warsaw University of Technology, Warsaw, Poland )
Carbon nanoparticles for future nanomedicine.
Marcin Kruszewski (Institute of Nuclear Chemistry and Technology, Warsaw, Poland )
New look into theranostic nanoparticles in nuclear medicine.
Anna Nowicka (University of Warsaw, Warsaw, Poland )
Nanosensors in POC diagnostics.
2:00 p.m. - 4:00 p.m.
Session 9: Advances in seizures and epilepsy research
Chairs - Tomasz Kocki (Poland ), Magdalena Bujalska-Zadrożny (Poland )
Chairs - Tomasz Kocki (Poland ), Magdalena Bujalska-Zadrożny (Poland )
Room: Medium Hall B
Speakers:
Camila V. Esguerra (Chemical Neuroscience Group, University of Oslo, Norway )
A common pathogenetic mechanism shared between early acute exposure to valproate and Dravet syndrome.
Rafał Kamiński (UCB Biopharma, Translational Medicine Neuroscience, Braine-l'Alleud, Belgium )
Novel approaches to discovery of future antiepileptic drug targets.
Urszula Doboszewska (Institute of Biology and Biochemistry, Maria Curie-Skłodowska University, Lublin, Poland )
The role of the GPR39 receptor in animal models of seizures and epilepsy.
Piotr Maciejak (Institute of Psychiatry and Neurology, Warsaw; Medical University of Warsaw, Centre for Preclinical Research and Technology (CePT), Warsaw, Poland )
Neurobiochemical mechanisms of a ketogenic diet: simple rules for a complex reality?
Camila V. Esguerra (Chemical Neuroscience Group, University of Oslo, Norway )
A common pathogenetic mechanism shared between early acute exposure to valproate and Dravet syndrome.
Rafał Kamiński (UCB Biopharma, Translational Medicine Neuroscience, Braine-l'Alleud, Belgium )
Novel approaches to discovery of future antiepileptic drug targets.
Urszula Doboszewska (Institute of Biology and Biochemistry, Maria Curie-Skłodowska University, Lublin, Poland )
The role of the GPR39 receptor in animal models of seizures and epilepsy.
Piotr Maciejak (Institute of Psychiatry and Neurology, Warsaw; Medical University of Warsaw, Centre for Preclinical Research and Technology (CePT), Warsaw, Poland )
Neurobiochemical mechanisms of a ketogenic diet: simple rules for a complex reality?
4:00 p.m. - 4:30 p.m.
Coffee Break
4:30 p.m. - 6:30 p.m.
Workshop: Recent advances in the theory and applications of biomedical systems.
Room: Seminar Room, Conference Room
Thermo Fisher Scientific
Maja Swoboda, Senior GA Systems Representative – Instruments, Poland
Recent advances in the theory and applications of biomedical systems.
(Seminar Room)
MERCK Life Science
Michał Konieczny, Field Application Manager, Eastern Europe & Russia
Designing experiments and data interpretation in cytometric analysis.
(Conference Room)
2018.
Due to the limited availability of seats, registration is strongly recommended.
Please visit the conference website: cebc.jordan.pl for registration via your account on 3 rd CEBC.
Maja Swoboda, Senior GA Systems Representative – Instruments, Poland
Recent advances in the theory and applications of biomedical systems.
(Seminar Room)
MERCK Life Science
Michał Konieczny, Field Application Manager, Eastern Europe & Russia
Designing experiments and data interpretation in cytometric analysis.
(Conference Room)
2018.
Due to the limited availability of seats, registration is strongly recommended.
Please visit the conference website: cebc.jordan.pl for registration via your account on 3 rd CEBC.
8:00 p.m. - 11:00 p.m.
Congress Dinner
Venue: Polish Aviation Museum
Venue: Polish Aviation Museum
September 18, 2018
8:00 a.m. - 10:00 a.m.
REGISTRATION
Venue: Auditorium Maximum, 33 Krupnicza Street
Venue: Auditorium Maximum, 33 Krupnicza Street
8:45 a.m. - 10:45 a.m.
Session 10: Pharmacology in the 21st century: opportunities and challenges
Session within the continuous training of professional Pharmacists
Chair - Andrzej Pilc (Poland )
Session within the continuous training of professional Pharmacists
Chair - Andrzej Pilc (Poland )
Room: Medium Hall A
Companies:
Branden Stansley (Vanderbilt University and Vanderbilt Medical Center, Nashville, USA )
Enhancing mGlu5 signaling for the treatment of cognitive impairment associated with schizophrenia: importance of signal bias and crosstalk with mGlu3.
Andrzej Pilc (Institute of Pharmacology PAS, Krakow, Poland )
Allosteric mGlu4 receptor modulators as antipsychotic-like drugs a crosstalk with 5-HT1A receptors.
Marta Dziedzicka-Wasylewska (Institute of Pharmacology PAS, Krakow, Poland )
Importance of GPCRs heteromerization in the central nervous system - dopamine receptors as an example.
Branden Stansley (Vanderbilt University and Vanderbilt Medical Center, Nashville, USA )
Enhancing mGlu5 signaling for the treatment of cognitive impairment associated with schizophrenia: importance of signal bias and crosstalk with mGlu3.
Andrzej Pilc (Institute of Pharmacology PAS, Krakow, Poland )
Allosteric mGlu4 receptor modulators as antipsychotic-like drugs a crosstalk with 5-HT1A receptors.
Marta Dziedzicka-Wasylewska (Institute of Pharmacology PAS, Krakow, Poland )
Importance of GPCRs heteromerization in the central nervous system - dopamine receptors as an example.
8:45 a.m. - 10:45 a.m.
Session 11: Scientific idea and what next - from molecule to implementation
Chairs - Magdalena Bujalska-Zadrożny (Poland ), Tomasz Kocki (Poland )
Chairs - Magdalena Bujalska-Zadrożny (Poland ), Tomasz Kocki (Poland )
Room: Medium Hall B
Speakers:
Konrad Korbiński (Synergia, Warsaw Medical University, Warsaw, Poland )
Productive and Safe Cooperation Between Scientists and Pharma Industry - safeguarding intellectual property and confidentiality.
Marcin Szczeciński (Adamed Holding, Poland )
Aspects to consider before launching and early on in a drug discovery program – pharmaceutical industry perspective.
Magdalena Bujalska-Zadrożny (Warsaw Medical University, Warsaw, Poland )
From basic research to medicinal product approval – a brief history of a novel formulation development.
Louis Boon (Bioceros BV, Utrecht, Netherlands )
Discovery of novel therapeutic antibodies using Bioceros CASHTM Platform.
Marcin Feder (Adamed Pharma S.A., Poland )
AD-O21.32 – from computationl modelling to preclinical anticancer drug candidate. Andrzej Kuśmierz (WAW.AC – Warsaw Technology Accelerator, Poland )
Breaking ice between industry and academia.
Konrad Korbiński (Synergia, Warsaw Medical University, Warsaw, Poland )
Productive and Safe Cooperation Between Scientists and Pharma Industry - safeguarding intellectual property and confidentiality.
Marcin Szczeciński (Adamed Holding, Poland )
Aspects to consider before launching and early on in a drug discovery program – pharmaceutical industry perspective.
Magdalena Bujalska-Zadrożny (Warsaw Medical University, Warsaw, Poland )
From basic research to medicinal product approval – a brief history of a novel formulation development.
Louis Boon (Bioceros BV, Utrecht, Netherlands )
Discovery of novel therapeutic antibodies using Bioceros CASHTM Platform.
Marcin Feder (Adamed Pharma S.A., Poland )
AD-O21.32 – from computationl modelling to preclinical anticancer drug candidate. Andrzej Kuśmierz (WAW.AC – Warsaw Technology Accelerator, Poland )
Breaking ice between industry and academia.
10:45 a.m. - 11:15 a.m.
Coffee break
11:15 a.m. - 12:00 p.m.
Plenary Lecture 3:
Csaba Földy - Brain Research Institute, University of Zurich, Switzerland
Single-cell transcriptomic survey of neural identity and circuit connectivity
Csaba Földy - Brain Research Institute, University of Zurich, Switzerland
Single-cell transcriptomic survey of neural identity and circuit connectivity
Room: Medium Hall
Chair: Rafał Olszanecki, Poland
12:00 p.m. - 1:00 p.m.
Lunch Break
Room: Exhibition Room
1:00 p.m. - 3:00 p.m.
Session 12: Young Scientific Investigators' Session
Chairs - Marzena Maćkowiak (Poland ), Edmund Przegaliński (Poland ) Dr. Grzegorz Sumara (Germany )
Chairs - Marzena Maćkowiak (Poland ), Edmund Przegaliński (Poland ) Dr. Grzegorz Sumara (Germany )
Room: Medium Hall
3:00 p.m. - 4:00 p.m.
Closing and Award Ceremony
Chairs - Małgorzata Filip (Poland ), Joanna Pera (Poland )
Chairs - Małgorzata Filip (Poland ), Joanna Pera (Poland )
Room: Medium Hall